Jason Bugno
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 5
- Polymers and Plastics top 5%
- Dendrimers and Hyperbranched Polymers 10
- Immunology top 10%
- Immune cells in cancer 4
- interferon and immune responses 3
- Immunotherapy and Immune Responses 3
- Pharmaceutical Science top 5%
-
- RNA Interference and Gene Delivery 10
-
- Cancer Immunotherapy and Biomarkers 3
-
- Advanced Polymer Synthesis and Characterization 2
- Co-authors
- Seungpyo HongHao-jui HsuHao‐Jui HsuLiangliang WangKaiting YangHua LiangRalph R. WeichselbaumDaniel D. Lantvit
- Journals
- Clinical Cancer Research (2 papers)Journal of Clinical Investigation (2 papers)Current Topics in Medicinal Chemistry (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Jason Bugno
19 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Biomaterials 275
- Polymers and Plastics 227
- Immunology 248
- Pharmaceutical Science 59
- Molecular Biology 578
Countries citing papers authored by Jason Bugno
This map shows the geographic impact of Jason Bugno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Bugno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Bugno more than expected).
Fields of papers citing papers by Jason Bugno
This network shows the impact of papers produced by Jason Bugno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Bugno. The network helps show where Jason Bugno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason Bugno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 13 | |
| 2 | 2024 | 23 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 30 | |
| 5 | 2023 | 18 | |
| 6 | Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigorationbreakdown → | 2022 | 154 |
| 7 | 2021 | 38 | |
| 8 | 2021 | 10 | |
| 9 | Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockadebreakdown → | 2021 | 220 |
| 10 | 2019 | 29 | |
| 11 | 2017 | 7 | |
| 12 | 2016 | 138 | |
| 13 | 2016 | 88 | |
| 14 | 2015 | 47 | |
| 15 | 2014 | 122 | |
| 16 | 2014 | 45 | |
| 17 | 2014 | 39 | |
| 18 | 2014 | 45 | |
| 19 | 2013 | 18 |
About Jason Bugno
Jason Bugno is a scholar working on Polymers and Plastics, Immunology, Biomaterials, Molecular Biology and Pharmaceutical Science, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Dendrimers and Hyperbranched Polymers (10 papers), RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (5 papers), Immune cells in cancer (4 papers), interferon and immune responses (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Advanced Polymer Synthesis and Characterization (2 papers). The work is most often cited by research in Biomaterials (275 citations), Polymers and Plastics (227 citations), Immunology (248 citations), Pharmaceutical Science (59 citations) and Molecular Biology (578 citations). Jason Bugno has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Seungpyo Hong, Hao-jui Hsu, Hao‐Jui Hsu, Liangliang Wang, Kaiting Yang, Hua Liang, Ralph R. Weichselbaum, Daniel D. Lantvit, Joanna E. Burdette and Suhair Sunoqrot. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Investigation, Current Topics in Medicinal Chemistry, Chemistry of Materials and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.